The Australian and New Zealand Risk of Death (ANZROD) model currently used for benchmarking intensive care units (ICUs) in Australia and New Zealand utilises physiological data collected up to 24 hours after ICU admission to estimate the risk of hospital mortality. This study aimed to develop the Australian and New Zealand Risk of Death admission (ANZROD 0 ) model to predict hospital mortality using data available at presentation to ICU and compare its performance with the ANZROD in Australian and New Zealand hospitals. Data pertaining to all ICU admissions between 1 January 2006 and 31 December 2015 were extracted from the Australian and New Zealand Intensive Care Society Adult Patient Database. Hospital mortality was modelled using logistic regression with development (two-thirds) and validation (one-third) datasets. All predictor variables available at ICU admission were considered for inclusion in the ANZROD 0 model. Model performance was assessed using Brier score, standardised mortality ratio and area under the receiver operating characteristic curve. The relationship between ANZROD 0 and ANZROD predicted risk of death was assessed using linear regression. After standard exclusions, 1,097,416 patients were available for model development and validation. Observed mortality was 9.5%. Model performance measures (Brier score, standardised mortality ratio and area under the receiver operating characteristic curve) for the ANZROD 0 and ANZROD in the validation dataset were 0.069, 1.0 and 0.853; 0.057, 1.0 and 0.909, respectively. There was a strong positive correlation between the mortality predictions with an overall R 2 of 0.73. We found that the ANZROD 0 model had acceptable calibration and discrimination. Predictions from the models had high correlations in all major diagnostic groups, with the exception of cardiac surgery and possibly trauma and sepsis.
Prognostic models and their use in predicting outcomes in critically ill patients have gained considerable support within the intensive care community worldwide 1 . The Acute Physiology and Chronic Health Evaluation (APACHE) [2] [3] [4] [5] , the Mortality Probability Model (MPM) [6] [7] [8] , and the Simplified Acute Physiology Score (SAPS) [9] [10] [11] [12] are the three most commonly used prediction models in adult intensive care units (ICUs) . There are also special models developed for regional applications using locally derived datasets, such as the Intensive Care National Audit and Research Centre model 13 and the Australian and New Zealand Risk of Death (ANZROD) model 14, 15 . These models provide a valuable framework to describe severity of illness of patients for evaluation of ICU performance, quality improvement and benchmarking 16 .
Although the above models have good performance, they are heavily based on physiological measurements to provide estimates of predicted mortality. The collection of laboratory data for these models requires considerable effort, making their use difficult in resource-constrained settings 1 . The assumption of missing physiological data as normal may further adversely affect the performance of severity scores of these models 17 . Hence, patient severity models based on data available at the time of ICU admission, which exclude physiological data, might be of benefit as they not only reduce the data collection burden but also provide baseline estimates of mortality risk independent of treatment in the ICU 7 . In addition, such models have the potential to be used as decision support for ICU admission triage and risk stratification 17 because all the predictor variables are available at admission. Furthermore, admission models can be used to assess quality of ICU care provided to patients 8, 18, 19 as these models are not influenced by the technical factors involved in the processes of care in the ICU. Among the main prognostic models, SAPS 3 11, 12 and MPM [6] [7] [8] 20 are examples of admission models which utilise data collected before or within one hour of ICU admission.
The Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcome and Resource Evaluation (CORE) currently uses the ANZROD model 14, 15 for benchmarking ICU outcomes in Australian and New Zealand (ANZ) ICUs. ANZROD is a prediction model that was developed for use in ANZ ICUs to overcome the deficiencies 21 of APACHE III-j. This model has been shown to be a better risk adjustment tool for benchmarking ICU outcomes 22 in ANZ hospitals. However, as this model uses physiological data collected up to 24 hours after admission to provide estimates of predicted mortality, it cannot provide an estimate of risk of death at the time of entry into the ICU. An admission model developed from data available at presentation would be simpler to implement. It would reduce the burden of data collection to variables that are routinely collected, and would be much easier to use in resource-constrained ICUs. Also, development of such a model includes all patients with missing physiological data who were necessarily excluded from the development of the ANZROD model, and thus enables the development of a model covering a larger ICU population. It was hypothesised that a predictive model with good discrimination and calibration could be developed using data available at presentation to the ICU. Therefore, the aim of the present study was to develop and validate the Australian and New Zealand Risk of Death admission model (ANZROD 0 ) and assess its performance in specific subgroups (e.g. diagnosis categories) of the ICU population. More specifically, the authors sought to compare the performance of ANZROD 0 against the ANZROD model for predicting hospital mortality in adult patients admitted to ANZ ICUs and to develop a simple translational formula to estimate the ANZROD predicted risk of death using ANZROD 0 risk of death.
Materials and methods
Data were extracted from the ANZICS Adult Patient Database (APD), one of the four registries run by the ANZICS CORE. This bi-national dataset 23 contains more than 1.6 million individual ICU episodes of care, making it one of the largest repositories of ICU patient information in the world. Presently, the APD receives data from approximately 130,000 ICU admissions each year, representing more than 80% of all adult ICU admissions in ANZ 24 . Data are submitted on behalf of each ICU director, and each hospital allows subsequent use as appropriate under the ANZICS CORE standing procedures and in compliance with the ANZICS CORE terms of reference.
All patients 16 years of age and above whose data were submitted to ANZICS APD between 1 January 2006 and 31 December 2015 were included in this study. We excluded readmission episodes to an ICU within the same hospital stay, patients admitted for palliative care and organ donation, and those with missing hospital outcomes.
The ANZROD model also excluded patients with a missing Acute Physiology score on ICU Day 1 in keeping with the methodology 14 . Access to the data was granted by the ANZICS CORE Management Committee in accordance with standing protocols. All extracted data were de-identified, and the study was conducted with the approval of the Monash University Human Research Ethics Committee.
Information extracted for each patient included age, location before ICU admission, surgical status, admission diagnosis, presence of chronic illnesses and presence of treatment limitations. The outcome considered was 'in-hospital mortality'. Patients who were discharged home, transferred to a chronic care/rehabilitation hospital, transferred to another hospital ICU or transferred to another acute care hospital were regarded as not having had this outcome. To develop the ANZROD 0 model, the extracted data was randomly split into derivation (67%) and validation (33%) datasets. The derivation dataset was used for prediction model construction, whereas the validation dataset was used to test the performance of the developed model. Derivation and validation datasets were mutually exclusive. Physiological data and ventilation status were also extracted from the APD to calculate the ANZROD probability of death for comparing the performance of the two models.
Statistical analysis
Analyses were performed with SAS software version 9.4 (SAS Institute, Cary, NC, USA) or Stata software version 14 (StataCorp, TX, USA). The ANZROD 0 model was constructed using the following steps:
Step 1: Identification of candidate variables All variables from the original ANZROD model, with the exception of Acute Physiology score components and ventilation status, were considered for inclusion in ANZROD 0 . Table 1 presents the list of all potential variables that were selected for inclusion in the model.
Step 2: Development of the model
We estimated the probability of in-hospital death for each patient in the development dataset using a multiple logistic regression equation. All variables listed in Table 1 were initially included in the model.
The model chi-square was calculated for each variable to adjudge the relative importance of that variable. A priori criteria for model performance were an area under the receiver operating characteristic (AUROC) curve of ≥0.85 and acceptable calibration (Brier score 19 <0.1 and standardised mortality ratio [SMR] 1.0). Several models were constructed by adding or deleting individual variables, and their performance was compared by evaluating calibration and discrimination parameters. The model that displayed best discrimination with the least difference between observed and predicted mortality was selected as the final model.
Step 3: Validation of the model Performance of ANZROD 0 was assessed in the validation sample. ANZROD 0 predictions were compared with the original ANZROD predictions for each patient in a common dataset within the validation sample. Statistical measures of model accuracy were used to compare ANZROD and ANZROD 0 . Discrimination assesses the probability that a model will assign a higher mortality probability to a nonsurvivor than to a survivor, and was assessed by AUROC 25 . Calibration assesses a model's accuracy across the whole cohort and was measured using the Brier score 26 , adjusted Brier score 27 , SMR and Hosmer-Lemeshow C statistic 28 .
Step 4: Development of the translational equation
The distributions of the predicted risk of death of ANZROD and ANZROD 0 models were found to be approximately normal after logarithmic transformation. Linear relationships between predicted risk of death (ROD) from both models were fitted using linear regression in a common dataset. Estimates of the intercept and slope parameters and the coefficient of determination (R 2 ) were reported.
Results
We analysed data for 1,187,555 ICU admissions submitted to ANZICS APD between 1 January 2006 and 31 December 2015. Of these, 1,097,416 admissions met the inclusion criteria and were used for model development and validation ( Figure 1) . Table 2 presents a descriptive analysis of the patients included in the study. There were higher percentages of male patients, patients admitted for emergency surgery, and patients admitted to the ICU from the emergency or operating rooms in the entire study cohort. Overall, ICU mortality was 6% and in-hospital mortality was 9.5%. About a quarter of patients had one or more chronic illnesses.
The measures of model performance for ANZROD 0 in the development and validation samples are presented in Table 3 . The ANZROD 0 model had an AUROC of 0.851 (95% confidence interval [CI] 0.849 to 0.853) and an adjusted Brier score of 0.19 in the validation sample. The validationset SMRs across major diagnostic groups ranged between 0.97 and 1.06.
Measures comparing the performance of ANZROD and ANZROD 0 in a common dataset within the validation sample are given in Table 4 . The ANZROD 0 model had lower AUROC and adjusted Brier values compared to ANZROD but the SMR was similar for both models.
Calibration curves ( Figure 2) show slightly better performance for ANZROD in higher risk deciles at the upper end of the curve. Performance of models across age categories is depicted in Figure 3 .
Correlation between mortality probabilities predicted from each of the two models, and the association of mortality probabilities of ANZROD predicted using ANZROD 0 with observed mortality in major diagnostic groups are presented in Tables 5 and 6 .
Correlation between predicted mortality probabilities from the two models was 0.73, with correlations within major diagnostic groups ranging from 0.33 to 0.8. The ANZROD predicted risk of death derived using ANZROD 0 had an AUROC of 0.8 or higher in five out of eight major diagnostic groups.
Appendix 1 shows the translational equations developed to estimate ANZROD predicted ROD using ANZROD 0 in major diagnostic groups. Performance of ANZROD 0 in diagnostic categories is shown in Appendix 2. The parameters of ANZROD 0 model are displayed in Appendix 3. Four of the seven APACHE III chronic health variables (acquired immune deficiency syndrome, hepatic failure, lymphoma and immunosuppression), source of admission to hospital and one of the APACHE II chronic health variables (chronic cardiovascular disease) were removed from the model due to small chi-square values.
Discussion
We have developed a new risk prediction model for in-hospital mortality in ANZ critical care, the ANZROD 0 model, based on data collected prior to ICU admission. ANZROD 0 estimates mortality probability at hospital discharge using 11 variables obtained at the time of ICU admission. This model is complementary to our previously reported ANZROD model, allowing in-hospital mortality risk to be estimated independently of care received within the ICU. When applied to a cohort of admissions eligible for both models, ANZROD 0 has comparable performance to ANZROD on measures of calibration and discrimination. The present study serves to develop and validate an admission model to be used in Australasian hospitals. Although adult ICU prognostic models were introduced in intensive care over 30 years ago, APACHE 2-5 , the most widely used scoring system in the medical literature 17 , was developed using physiological data collected within 24 hours of ICU stay. MPM [6] [7] [8] was the first admission model to be used for predicting mortality among adult ICU patients, which was then followed by the development of the SAPS 3 11,12 model. Although MPM 20 and SAPS 3 29 have good performance, they may not perform well in ANZ ICU population 14 due to differences in case-mix of the patients in the data used to develop these models; therefore a new model specifically tailored to the Australasian ICU population is needed.
The ANZROD 0 is a 'true' admission model developed for use among critically ill adult patients admitted in Australasian hospitals. Compared to MPM 0 -III 8 and SAPS 3 11, 12 , this model has been developed using data available at the time of ICU admission. Although the majority of predictor variables included in SAPS 29 and MPM 20 models are collected before the commencement of ICU care, they also include variables collected up to one hour after ICU admission. In addition, these models utilise some amount of physiological data to estimate the predicted risk of death. SAPS 3 11, 12 uses ten clinical and laboratory physiological variables 17 whereas MPM 0 -III 8 employs three clinical physiological variables 17 in the probability of death calculations. In contrast, ANZROD 0 is a 'true' admission model as it has been developed using predictor variables collected exclusively before the start of ICU care, and thus provides the 'true' ROD at ICU admission for adult patients admitted to ANZ ICUs.
Our analysis showed that the ANZROD model has superior performance than ANZROD 0 in the validation cohort ( Figure  2) . When assessed in a common dataset, ANZROD had better discrimination (AUROC 0.909 versus 0.853) and calibration (Brier score 0.057 versus 0.069) compared to the admission model (Table 4 ). This result agrees with what Keegan et al 30 and Bohensky et al 31 found previously. They showed that models with more predictor variables performed better than those with fewer variables. The better performance of ANZROD may be attributed to the predictive ability of physiological variables and ventilation status included in the model, and may in part be due to the overlap between the dataset used to validate the models here and that used to develop ANZROD. The Hosmer-Lemeshow C statistic had a P value of <0.0001 for ANZROD 0 in both the development and validation samples. Given the large sample size, such statistical significance is expected, and is not necessarily indicative of a poor model fit 32 . Table 5 Correlation between log-transformed predicted mortality probabilities estimated from the studied models in the validation dataset Despite the slightly worse performance, the SMR calculated in the validation sample of ANZROD 0 was comparable to that of the ANZROD model suggesting its potential use in benchmarking.
We found that the ANZROD 0 performs better in some subgroups than others in the validation sample. Although the model had good performance in most diagnostic groups, performance varied across age groups (Figure 3 ) and hospital types. The ratio of observed to mean predicted hospital mortality ranged between 0.9 and 1.10 for over 70% (89/124) of the diagnoses, and 92% (114/124) of SMRs within disease groups are not significantly different from one with the 95% CIs for SMRs including the value one (Appendix 2). In contrast, six out of eight age groups had SMRs significantly different from one. Among the hospital types, the SMR was significantly different from one for all except metropolitan hospitals. Although such differences in model performance over subgroups is consistent with previous research 14, [33] [34] [35] [36] and most likely due to the effect of case-mix variation, this suggests the need for prospective evaluation of the ANZROD 0 to assess its performance in different subgroups of the ICU population.
In an attempt to develop a translational equation to estimate ANZROD predicted ROD using ANZROD 0 , the correlation between ROD of both models was assessed in major diagnostic groups in a common dataset within the validation sample. The relationship between ROD was found to be stronger for certain diagnoses, including respiratory and neurological, whereas a weaker relationship was found for coronary artery bypass graft and valve surgery patients ( Table 5 ). It may be that the predictive ability of physiological data is reflected through the correlations observed in these diagnoses. Although physiological data are important for predicting mortality with certain diagnoses, these effects are likely not consistent across all diagnostic groups. The findings of the present study may suggest a possible influence of physiological data on mortality in cardiac surgery patients and is consistent with previous studies 13,37-40 conducted elsewhere. Moreover, the results also suggest the need for further research to assess performance of ANZROD 0 in sepsis and trauma patients before it can be applied to these specific patient subgroups. The ANZROD 0 model has the potential to be used as a tool for risk adjustment in benchmarking and performance comparison of ICUs where resources are limited. This model is based on data available at ICU admission and therefore reduces data collection burden. Furthermore, it has comparable accuracy with ANZROD in most diagnostic groups with the exception of cardiac surgery and possibly trauma and sepsis. Nevertheless, the ability of ANZROD 0 to identify potential outlier ICUs in ANZ hospitals requires further research.
The main strength of this study is the large, representative dataset covering more than 80% of the ANZ ICU population in which the model was developed. Another strength is the fewer exclusions for ANZROD 0 ; patients with missing physiological data are not excluded from ANZROD 0 , whereas they are excluded from ANZROD. This is the first study to develop an admission model for modern intensive care practice in ANZ ICUs. The simplicity and adequate performance of the model means that risk prediction and benchmarking of outcomes can now be provided to ICUs which are unable to collect full and accurate physiological and biochemical data for ANZROD.
Limitations
Our study has several limitations. First, the ICUs were all located in Australia and New Zealand, limiting the model's generalisability to other countries. Second, we did not model hospital mortality as a mixed-effects model, that is, with hospitals and ICUs as nested clusters, because we were interested in creating a general predictive model, rather than examining factors influencing hospital mortality. Additionally, like any model predicting hospital outcome, ANZROD 0 is intended to evaluate groups of patients and cannot be expected to predict outcome for individual patients with complete accuracy. The model was developed and validated on a large group of patients. It appears useful in comparing outcomes in most groups of patients with the exception of cardiac surgery (and possibly trauma and sepsis). In addition, it would be inappropriate to use this model to plan treatment or admission to the ICU based on an estimated predicted ROD, without considering several other factors including patient and family preferences, unmeasured risk factors and ICU resources. 
Conclusion
The ANZROD 0 is an admission model developed for use among critically ill adult patients in ANZ ICUs. Its predictions of hospital mortality have acceptable calibration and discrimination and are complementary to the ANZROD model, allowing in-hospital mortality risk to be estimated independently of care received within the ICU. The correlation between predicted mortality probabilities from ANZROD 0 and ANZROD was high in all major diagnostic groups with the exception of cardiac surgery and possibly trauma and sepsis. Although ANZROD 0 may be of use in resource-constrained ICUs, further assessment is required before recommending its introduction into routine practice.
Appendix 1
Translational equations in major diagnostic groups in the validation dataset 
